In light of the renewed spread of Covid in Israel in recent weeks, the Israeli Ministry of Health instructed the health insurance funds today to administer a third dose of Pfizer vaccine to immunosuppressed people. The aim is to prevent them from becoming infected and developing severe forms of the disease.
Covid, Delta reduces the effectiveness of vaccines? No, we are avoiding serious cases
by Noemi Penna
A statement from the Ministry of Health specifies that the measure concerns those who have had heart, lung, liver, bone marrow or kidney transplants. The third dose can also be administered to those who have been or are still undergoing various types of oncological treatments.
Pfizer Loses Effect Against Delta Variant: Israeli Announcement
The optimal period for vaccination with the third dose – according to the ministry – is eight weeks after the second. In any case, he warns, no less than four weeks should elapse between the second and third dose. Immunosuppressed, warns the ministry of health, must however continue to maintain maximum caution. Among other things, they are encouraged to wear protective masks, to observe personal hygiene and to refrain from contact with sick or unvaccinated people.
Covid vaccine, Pfizer will seek authorization for the third dose. But the Fda and the CDC are holding back
by Daniele Banfi
Last Thursday Pfizer-BionTech announced that it intends to seek authorization from the American FDA for a third dose of the vaccine developed specifically against the delta variant which will soon become the predominant one all over the world.
The pharmaceutical company had explained that there are “encouraging data”, but in a joint note the Fda and the Cdc (Centers for Disease Control) had questioned the need, arguing that at the moment there is no scientific evidence that suggests the need for a recall. .
Pfizer plans to meet with top U.S. health officials today to discuss applying for federal authorization for a third dose of its vaccine, as Anthony Fauci, medical adviser to President Joe Biden, acknowledged that “it is entirely conceivable, perhaps likely” that recalls will be needed in the future.
In a statement to the Associated Press, Dr. Mikael Dolsten Pfizer said early data from the company’s booster study suggests people’s antibody levels rise five to ten times after a third dose, compared with their second dose months earlier.
Covid vaccines: with Pfizer or Moderna the third dose may not be needed
Fauci did not rule out the possibility yesterday, but said it was too early for the government to recommend a booster of the vaccine. Fauci agreed with the position of the FDA and the CDC not to consider the recalls necessary “at this time”.
“This does not mean that we stop here – Fauci specified – There are ongoing studies now underway as we talk about examining the feasibility of if and when we should give people a call.”
According to medical adviser Joe Biden, it is quite possible in the coming months “as the data evolves” the government could urge a recall based on factors such as age and underlying medical conditions. “Certainly it is entirely conceivable, perhaps sooner or later, we will need a recall”, concluded Fauci.
.